Key facts
- This page summarizes Jeffrey S. Hackman's Form 4 filing for FENNEC PHARMACEUTICALS INC. (FENC).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 19 May 2025, 17:42.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Purchase
Additional SEC filing notes
Footnote F1
Transaction Code P - Open market or private purchase of non-derivative or derivative security